Technical Analysis for IGMS - IGM Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 8.01 | 0.88% | 0.07 |
IGMS closed up 0.88 percent on Thursday, September 28, 2023, on 88 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 9 hours ago |
| 60 Minute Opening Range Breakout | about 9 hours ago |
| Up 2% | about 9 hours ago |
| Down 3% | about 13 hours ago |
| Down 2 % | about 13 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2023
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Immunoglobulin M Protein Engineering
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Immunoglobulin M Protein Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 28.2 |
| 52 Week Low | 6.45 |
| Average Volume | 217,421 |
| 200-Day Moving Average | 13.78 |
| 50-Day Moving Average | 8.12 |
| 20-Day Moving Average | 7.32 |
| 10-Day Moving Average | 7.46 |
| Average True Range | 0.51 |
| RSI (14) | 57.08 |
| ADX | 14.98 |
| +DI | 24.56 |
| -DI | 14.56 |
| Chandelier Exit (Long, 3 ATRs) | 6.63 |
| Chandelier Exit (Short, 3 ATRs) | 7.99 |
| Upper Bollinger Bands | 8.01 |
| Lower Bollinger Band | 6.63 |
| Percent B (%b) | 1.0 |
| BandWidth | 18.90 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.1499 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.72 | ||||
| Resistance 3 (R3) | 8.69 | 8.43 | 8.60 | ||
| Resistance 2 (R2) | 8.43 | 8.25 | 8.44 | 8.56 | |
| Resistance 1 (R1) | 8.22 | 8.14 | 8.33 | 8.25 | 8.52 |
| Pivot Point | 7.96 | 7.96 | 8.01 | 7.97 | 7.96 |
| Support 1 (S1) | 7.75 | 7.78 | 7.86 | 7.78 | 7.50 |
| Support 2 (S2) | 7.49 | 7.67 | 7.50 | 7.46 | |
| Support 3 (S3) | 7.28 | 7.49 | 7.42 | ||
| Support 4 (S4) | 7.31 |
